Japan Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD07767
Publication Date March 2009
Publisher Global Markets Direct
Product Type Report
Pages 95
ISBN Number not applicable
Change currency
PDF £1,580.00 €1,903 $2,498 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Japan Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to the Japan diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in Japan

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in Japan.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in Japan.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 Diabetic Care Devices
    • 3.2 Glucose Monitoring Devices
      • 3.2.1 Blood Glucose Meters
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 InsulinPens
      • 3.3.2 Insulin Syringes
      • 3.3.3 Insulin Pumps
      • 3.3.4 Traditional Insulin Pump Accessories
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Market Authorization Holder (MAH)
      • 5.1.2 Classification and Pre-Market Approval of Medical Devices
      • 5.1.3 Third Party Certification for Controlled Medical Devices
      • 5.1.4 PMDA Approval for Highly Controlled Medical Devices
      • 5.1.5 Registration Time
      • 5.1.6 Registration Fee
      • 5.1.7 Post Marketing Surveillance
      • 5.1.8 Labeling and Packaging
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Reimbursement Policies
    • 6.3 Reimbursement Classes
      • 6.3.1 Class A
      • 6.3.2 Class B
      • 6.3.3 Class C
      • 6.3.4 Class F
    • 6.4 Request for Reimbursement
    • 6.5 Reduction in Reimbursement for Medical Devices and Drugs
  • 7 Distribution Structure
  • 8 Diabetes Care Devices In Japan
    • 8.1 Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Diabetes Care Devices, Japan, Overall Revenue ($ mn), 2000-2015
    • 8.3 Diabetes Care Devices, Japan, Category Volume (Units) by Segment, 2000-2015
    • 8.4 Diabetes Care Devices, Japan, Company Share (2006-2007)
  • 9 Glucose Monitoring In Japan
    • 9.1 Glucose Monitoring Overall Revenue (2000-2015)
    • 9.2 Glucose Monitoring Overall Volume (2000-2015)
    • 9.3 Glucose Monitoring Average Price (2000-2015)
    • 9.4 Glucose Monitoring Distribution Share (2007-2008)
    • 9.5 Glucose Monitoring, Japan, Company Share (2006-2007)
  • 10 Insulin Delivery In Japan
    • 10.1 Insulin Delivery Overall Revenue (2000-2015)
      • 10.1.1 Insulin Pens Revenue (2000-2015)
    • 10.2 Insulin Delivery Overall Volume (2000-2015)
      • 10.2.1 Insulin Pens Volume (2000-2015)
    • 10.3 Insulin Delivery Average Price (2000-2015)
    • 10.4 Insulin Delivery Distribution Share (2007-2008)
    • 10.5 Insulin Delivery, Japan, Company Share (2006-2007)
  • 11 Overview of Key Companies in Japan Diabetes Care Devices Market
    • 11.1 ARKRAY, Inc. Company Profile
      • 11.1.1 Company Overview
      • 11.1.2 ARKRAY, Inc. Pipeline Products
    • 11.2 Terumo Corporation Company Profile
      • 11.2.1 Company Overview
      • 11.2.2 Value Chain Analysis
    • 11.3 F. Hoffmann-La Roche Ltd. Company Profile
      • 11.3.1 Company Overview
      • 11.3.2 Value Chain Analysis
      • 11.3.3 F. Hoffmann-La Roche Ltd Pipeline Products
    • 11.4 Bayer HealthCare AG Company Profile
      • 11.4.1 Company Overview
      • 11.4.2 Value Chain Analysis
      • 11.4.3 Bayer HealthCare AG Pipeline Products
    • 11.5 Abbott Laboratories Company Profile
      • 11.5.1 Company Overview
      • 11.5.2 Value Chain Analysis
      • 11.5.3 Abbott Laboratories Pipeline Products
    • 11.6 LifeScan, Inc. Company Profile
      • 11.6.1 Company Overview
      • 11.6.2 LifeScan, Inc. Pipeline Products
    • 11.7 Medtronic, Inc. Company Profile
      • 11.7.1 Company Overview
      • 11.7.2 Value Chain Analysis
      • 11.7.3 Medtronic, Inc. Pipeline Products
    • 11.8 Novo Nordisk A/S Company Profile
      • 11.8.1 Company Overview
      • 11.8.2 Novo Nordisk A/S Pipeline Products
  • 12 Recent Developments
    • 12.1 Strategy and Business Planning
      • 12.1.1 Apr 28, 2008: Terumo Opens Office In Switzerland
      • 12.1.2 Apr 07, 2008: Terumo To Construct A New Extension To Ashitaka Factory For Increased Production Of Interventional Products
  • 13 Appendix
    • 13.1 Global Markets Direct Research Methodology
    • 13.2 Coverage
    • 13.3 Secondary Research
    • 13.4 Primary Research
    • 13.5 Models
    • 13.6 Forecasts
    • 13.7 Expert Panel Validation
    • 13.8 Currency Conversion
    • 13.9 Contact Us
    • 13.10 Disclaimer
  • 1 List of Tables
    • Table 1: Healthcare Expenditure in Japan, 2000 - 2005
    • Table 2: Number of Healthcare Institutions in Japan, 1995 2004
    • Table 3: Number of Hospital Beds in Japan, 1995 2004
    • Table 4: Number of Medical Personnel in Japan, 1995 - 2004
    • Table 5: Number of Doctors by Specialty in Japan, 2003-2007
    • Table 6: Number of Medical Care Institutions and Beds in Japan, 2000 - 2004
    • Table 7: Registration Processing Time for Medical Devices in Japan, 2007
    • Table 8: Product Registration Fee for Medical Devices in Japan, 2007
    • Table 9: Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 10: Diabetes Care Devices, Japan, Overall Revenue ($ mn), 2000-2015
    • Table 11: Diabetes Care Devices, Japan, Portfolio Analysis, 2000-2015
    • Table 12: Diabetes Care Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 13: Diabetes Care Devices, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 14: Diabetes Care Devices, Japan, Category Volume (Units) by Segment, 2000-2015
    • Table 15: Diabetes Care Devices, Japan, Category Volume (Units) by Segment, Historic, 2000-2008
    • Table 16: Diabetes Care Devices, Japan, Category Volume (Units) by Segment, Forecast, 2008-2015
    • Table 17: Diabetes Care Devices, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 18: Glucose Monitoring, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 19: Glucose Monitoring, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 20: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2000-2008
    • Table 21: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 22: Glucose Monitoring, Japan, Average Price ($), Historic, 2000-2008
    • Table 23: Glucose Monitoring, Japan, Average Price ($), Forecast, 2008-2015
    • Table 24: Glucose Monitoring, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 25: Glucose Monitoring, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 26: Insulin Delivery, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 27: Insulin Delivery, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 28: Insulin Pens, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 29: Insulin Pens, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 30: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2000-2008
    • Table 31: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 32: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 33: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 34: Insulin Delivery, Japan, Average Price ($), Historic, 2000-2008
    • Table 35: Insulin Delivery, Japan, Average Price ($), Forecast, 2008-2015
    • Table 36: Insulin Delivery, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 37: Insulin Delivery, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 38: ARKRAY, Inc. Pipeline Products by Equipment Type
    • Table 39: ARKRAY, Inc. Pipeline Products by Development Stage
    • Table 40: ARKRAY, Inc. Pipeline Products by Clinical Trials
    • Table 41: ARKRAY, Inc. Pipeline Products by News Summary
    • Table 42: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
    • Table 43: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
    • Table 44: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
    • Table 45: Bayer HealthCare AG Pipeline Products by Equipment Type
    • Table 46: Bayer HealthCare AG Pipeline Products by Development Stage
    • Table 47: Bayer HealthCare AG Pipeline Products by Therapy Area
    • Table 48: Bayer HealthCare AG Pipeline Products by News Summary
    • Table 49: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 50: Abbott Laboratories Pipeline Products by Development Stage
    • Table 51: Abbott Laboratories Pipeline Products by Therapy Area
    • Table 52: Abbott Laboratories Pipeline Products by Clinical Trials
    • Table 53: Abbott Laboratories Pipeline Products by News Summary
    • Table 54: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 55: LifeScan, Inc. Pipeline Products by Development Stage
    • Table 56: LifeScan, Inc. Pipeline Products by Therapy Area
    • Table 57: LifeScan, Inc. Pipeline Products by Clinical Trials
    • Table 58: LifeScan, Inc. Pipeline Products by News Summary
    • Table 59: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 60: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 61: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 62: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 63: Medtronic, Inc. Pipeline Products By News Summary
    • Table 64: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 65: Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 66: Novo Nordisk A/S Pipeline Products By Therapy Area
    • Table 67: Novo Nordisk A/S Pipeline Products By Clinical Trials
    • Table 68: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Healthcare Expenditure in Japan, 2000 2005
    • Figure 2: Government and Private Healthcare Expenditure in Japan, 2005
    • Figure 3: Medical Device Classification in Japan, 2007
    • Figure 4: Approval Process for Controlled Medical Devices in Japan, 2007
    • Figure 5: Approval Process for Highly Controlled Medical Devices in Japan, 2007
    • Figure 6: Health Insurance Reimbursement Process in Japan, 2007
    • Figure 7: Distribution Structure for Medical Equipment in Japan, 2007
    • Figure 8: Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 9: Diabetes Care Devices, Japan, Overall Revenue ($ mn), 2000-2015
    • Figure 10: Diabetes Care Devices, Japan, Portfolio Analysis, 2000-2015
    • Figure 11: Diabetes Care Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 12: Diabetes Care Devices, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 13: Diabetes Care Devices, Japan, Category Volume (Units) by Segment, 2000-2015
    • Figure 14: Diabetes Care Devices, Japan, Category Volume (Units) by Segment, Historic, 2000-2008
    • Figure 15: Diabetes Care Devices, Japan, Category Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 16: Diabetes Care Devices, Japan, Company Share (%), 2007
    • Figure 17: Glucose Monitoring, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 18: Glucose Monitoring, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 19: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 20: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 21: Glucose Monitoring, Japan, Company Share (%), 2007
    • Figure 22: Insulin Delivery, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 23: Insulin Delivery, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 24: Insulin Pens, Japan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 25: Insulin Pens, Japan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 26: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 27: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 28: Insulin Delivery, Japan, Company Share (%), 2007
    • Figure 29: Terumo Corporation Value Chain Analysis
    • Figure 30: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 31: Bayer HealthCare AG Value Chain Analysis
    • Figure 32: Abbott Laboratories Value Chain Analysis
    • Figure 33: Medtronic, Inc. Value Chain Analysis
    • Figure 34: Global Markets Direct Methodology